CVSI Stock, CV Sciences Inc. Information

CV Sciences, Inc. is a life science company that operates through two segments, specialty pharmaceuticals and consumer products. The Company focuses on developing and commercializing proprietary prescription drugs utilizing synthetic cannabidiol CBD as the active pharmaceutical ingredient and is engaged in the development, manufacturing, marketing and sale of consumer products containing plant based CBD, which is refined into its own proprietary branded products. CV Sciences initial drug candidate CVSI is a chewing gum that combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at billion, growing to over billion in the next years.